Emerging drugs in peripheral arterial disease

Author： Tulsyan Nirman   Ouriel Kenneth   Kashyap Vikram S  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.11, Iss.1, 2006-03, pp. : 75-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cilostazol and peripheral arterial disease

By Pearce Lyndsay   Ghosh Jonathan   Counsell Andrew   Serracino-Inglott Ferdinand  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2683-2690

Informa Healthcare

Access to resources Recommend Favorite

Hypertension in Peripheral Arterial Disease

By  

Current Pharmaceutical Design, Vol. 10, Iss. 29, 2004-11 ,pp. : 3615-3620

Bentham Science Publishers

Access to resources Recommend Favorite

Antioxidants in Peripheral Arterial Disease

By  

Current Drug Targets, Vol. 4, Iss. 8, 2003-11 ,pp. : 651-655

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid Management and Peripheral Arterial Disease

By  

Current Drug Targets, Vol. 8, Iss. 4, 2007-04 ,pp. : 561-570

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammation in Peripheral Arterial Disease (PAD)

By  

Current Pharmaceutical Design, Vol. 18, Iss. 28, 2012-09 ,pp. : 4350-4357

Bentham Science Publishers

Access to resources Recommend Favorite